Literature DB >> 15355418

Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403.

C Grodet1, P F Dequin, S Watt, P Lanotte, C de Gialluly, M K Taha, J M Alonso, R Quentin, A Goudeau, L Mereghetti.   

Abstract

This report describes a meningococcal outbreak in France caused by Neisseria meningitidis B:15:P1.12 of sequence type 1403, which affected eight young patients, between November 2000 and February 2002. Epidemiological typing confirmed that a single strain was responsible. Favourable outcome, sequelae or death resulted in similar proportions as in other cases of meningococcal disease in France during the same period, but purpura was observed in all eight cases. The patients were aged between 14 and 28 years, whereas the median age of patients affected by other meningococcal strains during this period in the same area was 60.4 years.

Entities:  

Mesh:

Year:  2004        PMID: 15355418     DOI: 10.1111/j.1469-0691.2004.00935.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

Review 1.  Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.

Authors:  Paul Balmer; Cynthia Burman; Lidia Serra; Laura J York
Journal:  Hum Vaccin Immunother       Date:  2018-05-09       Impact factor: 3.452

2.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

3.  Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014-19.

Authors:  Pasquale Stefanizzi; Francesco Paolo Bianchi; Giuseppe Spinelli; Fabio Amoruso; Domenica Ancona; Paolo Stella; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2021-08-26       Impact factor: 3.452

Review 4.  Vaccination strategies for the prevention of meningococcal disease.

Authors:  Scott Vuocolo; Paul Balmer; William C Gruber; Kathrin U Jansen; Annaliesa S Anderson; John L Perez; Laura J York
Journal:  Hum Vaccin Immunother       Date:  2018-04-13       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.